NS 1209
Alternative Names: SPD 502Latest Information Update: 06 Dec 2010
Price :
$50 *
At a glance
- Originator NeuroSearch
- Class Amino acids; Antiepileptic drugs; Neuroprotectants; Oximes; Small molecules
- Mechanism of Action AMPA receptor antagonists; Metabotropic glutamate receptor 5 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain; Status epilepticus; Stroke
Most Recent Events
- 21 Jun 2007 NeuroSearch is seeking a partner to continue development of NS 1209 for Neuropathic pain and Status epilepticus (http://www.neurosearch.com)
- 13 Jun 2007 Discontinued - Phase-II for Stroke in Europe (IV)
- 31 Aug 2005 Phase-I/II clinical trials in Neuropathic pain in United Kingdom (IV)